COMMUNIQUÉS West-GlobeNewswire

SciCann Therapeutics launch liver disease research program in Tel Aviv University

21/01/2019 - 15:00

TORONTO and TEL AVIV, Israel, Jan. 21, 2019 (GLOBE NEWSWIRE) -- SciCann Therapeutics is pleased to announce that it has launched a novel sponsored research program in Tel Aviv University, focused on the field of liver [...]

Allocation of Share Options

21/01/2019 - 14:40

NASDAQ Copenhagen Report on transactions of executives and related parties in Coloplast shares and related securities. According to the Market Abuse Regulation art. 19 Coloplast is obliged to report on the transactions [...]

Physeon Positive Clinical Trial Results for its Veinplicity® Device Published in The Journal of Vascular Access

21/01/2019 - 14:00

Results Confirmed that Veinplicity Dilatory Effect is 38% Greater than Commonly Used Heat Packs SCHAFFHAUSEN, Switzerland, Jan. 21, 2019 (GLOBE NEWSWIRE) -- Physeon GmbH, (“Physeon” or the “Company”), a leading [...]

Sandoz Canada reçoit l’approbation de Santé Canada pour l’utilisation d’Erelzi® (étanercept) dans le traitement de l’arthrite psoriasique chez les patients adultes

21/01/2019 - 14:00

Erelzi est le seul biosimilaire d’étanercept indiqué pour réduire les signes et les symptômes de l’arthrite psoriasique chez les patients adultes. Jusqu’à 90 000 Canadiens et Canadiennes souffrent ou pourraient souffrir [...]

Novo Nordisk A/S - Share repurchase programme

21/01/2019 - 13:55

Bagsværd, Denmark, 21 January 2019 - On 5 November 2018, Novo Nordisk initiated a share repurchase programme in accordance with Article 5 of Regulation No. 596/2014 of the European Parliament and Council of 16 April [...]

Solo Growth Announces Update to Corporate Presentation

21/01/2019 - 13:00

CALGARY, Alberta, Jan. 21, 2019 (GLOBE NEWSWIRE) -- Solo Growth Corp.™ (the “ Company ” or “ Solo Growth ”) (TSXV: SOLO) is pleased to announce that we have updated our corporate presentation, which is now posted on our [...]

Nash Pharmaceuticals Announces 84% Reduction of Fibrosis by Additional Lead Compound In Second Pre-Clinical Study For Non-Alcoholic Fatty Liver Disease

21/01/2019 - 13:00

Compound Showed Marked Improvement Over Cenicriviroc VANCOUVER, British Columbia, Jan. 21, 2019 (GLOBE NEWSWIRE) -- Nash Pharmaceuticals Inc., a wholly owned subsidiary of Breathtec Biomedical Inc. (CSE: BTH ) (CNSX: [...]

FocusCura subsidiary Luscii will continue as independent company with partner OMRON Healthcare to accelerate their international expansion

21/01/2019 - 12:37

Joining forces supports hospitals in moving care towards the home AMSTERDAM, The Netherlands, Jan. 21, 2019 (GLOBE NEWSWIRE) -- Luscii, the e-health application for remote monitoring developed by FocusCura, is set to [...]

Immunicum AB (publ) Announces Publication of Phase I/II Clinical Trial Results of Ilixadencel in Advanced Hepatocellular Carcinoma in Frontiers in Oncology

21/01/2019 - 08:31

Press Release 21 January 2019 Immunicum AB (publ) Announces Publication of Phase I/II Clinical Trial Results of Ilixadencel in Advanced Hepatocellular Carcinoma in Frontiers in Oncology Immunicum AB (publ; IMMU.ST) [...]

Oasmia announces that the extraordinary general meeting 25 January 2019 is cancelled

21/01/2019 - 08:30

Oasmia Pharmaceutical AB (publ) (“Oasmia” or the ”Company”) hereby announces that the board of directors of the Company has resolved to cancel the extraordinary general meeting which was to be held 25 January 2019. [...]

Presentation of Clearside Biomedical’s Extension Study of PEACHTREE for XIPERE™ Exhibits Durability Following Second Dose

20/01/2019 - 17:15

ALPHARETTA, Ga., Jan. 20, 2019 (GLOBE NEWSWIRE) -- Clearside Biomedical, Inc. (NASDAQ:CLSD), a biopharmaceutical company dedicated to developing treatments that restore and preserve vision for people with serious eye [...]

Media Advisory: Top Smoking Cessation Experts Meet in Ottawa

19/01/2019 - 14:00

OTTAWA, Jan. 19, 2019 (GLOBE NEWSWIRE) -- National and international smoking cessation authorities are gathering in Ottawa today to attend the second and final day of the 11 th Annual Ottawa Conference: State of the Art [...]

Avis aux médias : Les plus grands experts de l’abandon du tabac se rassemblent à Ottawa

19/01/2019 - 14:00

OTTAWA, 19 janv. 2019 (GLOBE NEWSWIRE) -- Des experts du Canada et du monde entier se rassemblent à Ottawa aujourd’hui pour la deuxième et dernière journée de la 11 e Conférence annuelle d’Ottawa : Approches cliniques [...]

Les animaux de Taconic Biosciences effectuent la dernière mission à la Station spatiale internationale

18/01/2019 - 23:40

RENSSELAER, New York, 18 janv. 2019 (GLOBE NEWSWIRE) -- Taconic Biosciences, chef de file mondial dans la fourniture de modèles de rongeurs génétiquement modifiés, annonce l'achèvement d'une récente mission à la Station [...]

iKang Announces Completion of Going Private Transaction

18/01/2019 - 23:01

BEIJING, Jan. 18, 2019 (GLOBE NEWSWIRE) -- iKang Healthcare Group, Inc. (“iKang” or the “Company”) (Nasdaq: KANG), a major provider in China’s fast growing private preventive healthcare services market, today announced [...]

MPX Receives Final Court Approval for Arrangement with iAnthus

18/01/2019 - 23:00

NEW YORK and TORONTO, Jan. 18, 2019 (GLOBE NEWSWIRE) -- iAnthus Capital Holdings, Inc. (“ iAnthus ” or the “ Company ”), (CSE: IAN , OTCQB: ITHUF) and MPX Bioceutical Corporation (“ MPX ”) (CSE: MPX; OTC: MPXEF) are [...]

Bio-Path Holdings, Inc. Announces $1.7 Million Registered Direct Offering Priced At-the-Market

18/01/2019 - 18:31

HOUSTON, Jan. 18, 2019 (GLOBE NEWSWIRE) -- Bio-Path Holdings, Inc., (Nasdaq: BPTH) (Bio-Path), a biotechnology company leveraging its proprietary DNAbilize ® antisense RNAi nanoparticle technology to develop a portfolio [...]

Stemline Therapeutics Closes $92 Million Public Offering of Common Stock

18/01/2019 - 17:21

NEW YORK, Jan. 18, 2019 (GLOBE NEWSWIRE) -- Stemline Therapeutics, Inc. (Nasdaq: STML), a commercial-stage biopharmaceutical company focused on discovering, acquiring, developing and commercializing innovative oncology [...]

VitalHub Announces Closing of Strategic Private Placement with Industry Leaders

18/01/2019 - 17:10

TORONTO, Jan. 18, 2019 (GLOBE NEWSWIRE) -- VitalHub Corp. (the “Company”) (TSXV: VHI) is pleased to announce that it has completed a non-brokered private placement (the “Offering”) of units (“Units”) with the former [...]